Optimizing high-performance liquid chromatography method for quantification of glucosamine using 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate derivatization in rat plasma: Application to a pharmacokinetic study

Biomedical Chromatography

Volumn 22, Issue 11, 2008, Pages 1265-1271

  Wang, Xianhuo ^a   Chen, Xiang ^a   Chen, Lijuan ^a   Wang, Biqin ^b   Peng, Cheng ^c   He, Chunmei ^a   Tang, Minghai ^a   Zhang, Fan ^a   Hu, Jia ^a   Li, Rui ^a   Zhao, Xia ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN NORMAL UNIVERSITY   (China)

^c CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

AQC; Derivatization; Fluorescence; Glucosamine (GlcN); HPLC; Pharmacokinetic

Indexed keywords

ACETONITRILE; BODY FLUIDS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHARMACOKINETICS; RATS; SODIUM CHLORIDE;

6-AMINOQUINOLYL-N-HYDROXYLSUCCINIMIDYL CARBAMATE; 6-AMINOQUINOLYL-N-HYDROXYSUCCINIMIDYL CARBAMATES; AQUEOUS LAYER; DERIVATIZATIONS; GLUCOSAMINE; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HPLC; PHARMACOKINETIC STUDIES; QUANTITATIVE DETERMINATIONS; RAT PLASMA;

FLUORESCENCE;

6 AMINOQUINOLYL N HYDROXYSUCCINIMIDYL CARBAMATE; ACETIC ACID; ACETONITRILE; BORIC ACID; CARBAMIC ACID DERIVATIVE; GLUCOSAMINE; PLASMA PROTEIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ACCURACY; AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DERIVATIZATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG STRUCTURE; FEMALE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRECIPITATION; PROCESS OPTIMIZATION; QUANTITATIVE STUDY; RAT; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; SUPERNATANT; TIME TO MAXIMUM PLASMA CONCENTRATION; VALIDATION PROCESS;

RATTUS;

EID: 65949097482     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1056     Document Type: Article

References (21)

1. Aghazadeh-Habashi A, Sattari S, Pasutto F and Jamali F. Single dose pharmacokinetics and bioavailability of glucosamine in the rat. Journal of Pharmacy and Pharmaceutical Science 2002a; 5(2): 181-184.
2. Aghazadeh-Habashi A, Sattari S, Pasutto F and Jamali F. High performance liquid chromatographic determination of glucosamine in rat plasma. Journal of Pharmacy and Pharmaceutical Science 2002b; 5(2): 176-180.
3. Aghazadeh-Habashi A, Carran J, Anastassiades T and Jamali F. High performance liquid chromatographic determination of N-butyryl glucosamine in rat plasma. Journal of Chromatography B 2005; 819: 91-96.
4. Cohen SA, Tarvin TL and Bidlingmeyer BA. Modern Methods in Protein Chemistry. New York: Plenum Press, 1988; 207-213.
5. Cohen SA, DeAntonis K and Michaud DP. Techniques in Protein Chemistry. San Diego: Academic Press, 1993; 289-298.
6. Hanson RR. Oral glycosaminoglycans in the treatment of degenerative joint disease in horses. Equine Practice 1996; 18: 18-22.
7. Hanson RR, Smalley LR, Huff GK, White S and Hammad TA. Oral treatment with a glucosamine-chondroitin sulfate compound for degenerative joint disease in horses: 25 cases. Equine Practice 1997; 19: 16-20.
8. Hawker G. Update on the epidemiology of the rheumatic diseases. Current Opinion in Rheumatology 1997; 9: 90-94.
9. Honda S, Akao E, Suzuki S, Okuda M, Kakehi K and Nakamura J. High-performance liquid chromatography of reducing carbohydrates as strongly ultraviolet-absorbing and electrochemically sensitive 1- phenyl-3-methyl-5-pyrazolone derivatives. Analytical Biochemistry 1989; 180: 351-357.
10. Huang TM, Deng CH, Chen NZ, Liu Z and Duan GL. High performance liquid chromatography for the determination of glucosamine sulfate in human plasma after derivatization with 9- fluorenylmethyl chloroformate. Journal of Separation Science 2006a; 29: 2296-2302.
11. Huang TM, Cai L, Yang B, Zhou MX, Shen YF and Duan GL. Liquid chromatography with electrospray ionization mass spectrometry method for the assay of glucosamine sulfate in human plasma: validation and application to a pharmacokinetic study. Biomedical Chromatography 2006b; 20: 251-256.
12. Liang ZM, Leslie J, Adebowale A, Ashraf M and Eddington ND. Determination of the nutraceutical, glucosamine hydrochloride, in raw materials, dosage forms and plasma using pre-column derivatization with ultraviolet HPLC. Journal of Pharmaceutical and Biomedical Analysis 1999; 20: 807-814.
13. McNamara PS, Barr SC and Erb HN. Hematologic, hemostatic and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days. American Journal of Veterinary Research 1996; 57: 1390-1394.
14. McNamara PS, Johnston SA and Todhunter RJ. Slow-acting, disease-modifying osteoarthritic agents. Veterinary Clinics of North America-Small Animal Practice 1997; 27: 863-867.
15. Mora R, Berndt KD, Tsai H and Meredith SC. Quantitation of aspartate and glutamate in HPLC analysis of phenylthiocarbamyl amino acids. Analytical Biochemistry 1988; 172: 368-376.
16. Setnikar I, Giacchetti C and Zanolo G. Pharmacokinetics of glucosamine in the dog and in man. Arzneim-Forsch/Drug Research 1986; 36(I): 729-735.
17. Setnikar I, Palumbo R, Canali S and Zanolo G. Pharmacokinetics of glucosamine in man. Arzneim-Forsch/Drug Research 1993; 43(II): 1109-1113.
18. Shao Y, Alluri R, Mummert M, Koetter U and Lech S. A stability-indicating HPLC method for the determination of glucosamine in pharmaceutical formulations. Journal of Pharmaceutical and Biomedical Analysis 2004; 35: 625-631.
19. Strydom DJ and Cohen SA. Comparison of amino acid analyses by phenylisothiocyanate and 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate precolumn derivatization. Analytical Biochemistry 1994; 222: 19-28.
20. Wu YQ, Hussain M and Fassihi R. Development of a simple analytical methodology for determination of glucosamine release from modified release matrix tablets. Journal of Pharmaceutical and Biomedical Analysis 2005; 38: 263-269.
21. Yasser S, El-Saharty and Bary AA. High-performance liquid chromatographic determination of neutraceuticals, glucosamine sulphate and chitosan, in raw materials and dosage forms. Analytica Chimica Acta 2002; 462: 125-131.